Skip to main content
Equibles
PETV logo

PETV · PetVivo Holdings, Inc.

Track PETV — free

Use PETV with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about PETV

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.68 -0.01 (-1.45%) At close · Aug 14
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these consolidated financial statements are issued. ... Accordingly, management has concluded that substantial doubt about the Company's ability to continue as a going concern is not alleviated.”
View the 10-Q filed Aug 14, 2026
Market Cap
$25.94M
Shares
37.95M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.68 Open$0.70 Day$0.65–0.70 52W close$0.62–1.50 Avg vol 30d9K Short int20K · 0.1% float · 1.0d Short vol32% Last earningsMar 31, 2025 DataDec 2020–Aug 2026 Filing10-Q · Aug 14

Raw chart and full-history price indicators begin at the captured split on Dec 30, 2020; bars on opposite sides are not compared.

Up next

FQ2-27 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 14, 2026

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 14.3 · calm Equity put/call 0.52
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −26%
below
Price vs 50-day avg −10%
below
RSI (14) 46
neutral
MACD trend Positive
52-week position 6%
near low
Momentum
relative strength
Very Weak
1-month return −12%
trailing
6-month return −15%
trailing
YTD return −40%
this year
Relative strength −29%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Accumulating
+1 funds added
Insider flow Accumulating
Net +$100.0K over 90 days · 0% sells
Short interest Rising
0.05% of float · ▲ +1.4% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
1 holders — near 4-yr low, contrarian setup
Squeeze score 29
low risk · 0–100
Fundamentals
Weak
Revenue growth −91%
Y/Y
Gross margin 10594%
expanding
EPS growth +7%
Y/Y
Free cash flow $-6.1M
Balance sheet $269.9K
net debt
Quant / Vol
risk profile
Very High
Volatility 75%
annualized · 1-yr
Max drawdown −58%
past year
ATR 8.2%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 2 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−26% Bearish
Price vs 50-day avg
−10% Bearish
RSI (14)
46 Neutral
MACD trend
Positive Bullish
52-week position
6% Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Accumulating
+1 funds added
Insider flow Accumulating
Net +$100.0K over 90 days · 0% sells
Short interest Rising
0.05% of float · ▲ +1.4% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
1 holders — near 4-yr low, contrarian setup
Price context
position in its 52-week range
Range low $1 Now $1 · 6% Range high $2
vs 200-day avg -26% vs 50-day avg -10%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
PETV
PetVivo Holdings, Inc.
this stock
$25.94M -40.4% -90.5% — 0.1%
ABT
Abbott Laboratories
 $194.07B -11.2% +5.7% 31.2 1.3%
SYK
Stryker Corp
 $133.18B -3.5% +11.2% 36.0 2.2%
MDT
Medtronic plc
 $116.83B -5.0% +8.4% 24.5 1.4%
BSX
Boston Scientific Corp
 $75.11B -45.6% +12.5% 21.0 1.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
1
% held
0.1%
Net QoQ
+48.1K sh
Top holder
Vermillion Wealth Managem…
Held Float
View
Short & Settlement
Short Interest Rising
Shares short
20.4K
Days to cover
1.0d
Change
+290 sh
View
Short Volume
Short vol %
32%
As of
Aug 10, 2026
Short Total
View
Fails to Deliver
FTD shares
137
Value
$110
As of
Jul 10, 2026
View
Off-Exchange
Off-exchange %
99.5%
Week of
Jul 6, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$100.0K
Buyers / Sellers
1 / 0
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$1.1M
Net income (FY)
$-10.5M
EPS diluted
$-0.38
View
Filings
SEC Filings
Latest
10-Q
Filed
Aug 14, 2026
This year
14
View
Earnings & Events
Earnings Calls
Last call
Mar 31, 2025
View

Performance

Raw-price comparisons begin at the captured split on Dec 30, 2020; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
PETV +4.6% -11.6% -15.0% -1.3% -40.4%
SPY +0.4% +4.5% +13.8% +3.9% +13.9%
vs SPY +4.2% -16.0% -28.8% -5.2% -54.2%
Key facts CIK 1512922 CUSIP 716817408 13F (30d) 2 filings 2 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)